Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3128540 | 0.94 | ALDH1A1 (0.47) | ALDH1A1THRBMEN1KMT2A | |
| SCHEMBL1764748 | 0.91 | ALDH1A1 (0.47) | ALDH1A1THRBMEN1KMT2AALOX5 | |
| SCHEMBL9887510 | 0.91 | ALDH1A1 (0.47) | ALDH1A1THRBMEN1KMT2AALOX5 | |
| SCHEMBL12555016 | 0.91 | ALDH1A1 (0.47) | ALDH1A1THRBMEN1KMT2AALOX5 | |
| SCHEMBL9886936 | 0.91 | ALDH1A1 (0.47) | ALDH1A1THRBMEN1KMT2AALOX5 | |
| SCHEMBL9359595 | 0.91 | ALDH1A1 (0.47) | ALDH1A1THRBMEN1KMT2AALOX5 | |
| SCHEMBL24083362 | 0.90 | ALDH1A1 (0.44) | ALDH1A1THRBMEN1KMT2A | |
| SCHEMBL24170123 | 0.88 | ALDH1A1 (0.44) | ALDH1A1THRBMEN1KMT2A | |
| SCHEMBL12689882 | 0.88 | ALDH1A1 (0.44) | ALDH1A1THRBMEN1KMT2A | |
| SCHEMBL12540471 | 0.88 | ALDH1A1 (0.44) | ALDH1A1THRBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220193210-A1 | THERAPEUTICS FOR AUTOIMMUNE KIDNEY DISEASE: SYNTHETIC ANTIGENS | DANMARKS TEKNISKE UNIVERSITET (DK) | 2022-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220193210-A1 | THERAPEUTICS FOR AUTOIMMUNE KIDNEY DISEASE: SYNTHETIC ANTIGENS | SSB, HAVCR2, CD47 | ALDH1A1 3142/4885THRB 1243/4885MEN1 1723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.